Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197 (Q73947936)
Jump to navigation
Jump to search
scientific article published on 01 December 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197 |
scientific article published on 01 December 1997 |
Statements
Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197 (English)
M Saag
D D Richman
T C Meng
K E Squires
J Holden-Wiltse
1 December 1997